Supplemental material
Open access
9,049
Views
182
CrossRef citations to date
0
Altmetric
Report
A strategy for risk mitigation of antibodies with fast clearance
Isidro Hötzel Antibody Engineering Department; Genentech, Inc.; South San Francisco, CA USA
, Frank-Peter Theil Early PK/PD Department; Genentech, Inc.; South San Francisco, CA USA
, Lisa J. Bernstein Biostatistics Department; Genentech, Inc.; South San Francisco, CA USA
, Saileta Prabhu Early PK/PD Department; Genentech, Inc.; South San Francisco, CA USA
, Rong Deng Early PK/PD Department; Genentech, Inc.; South San Francisco, CA USA
, Leah Quintana Early PK/PD Department; Genentech, Inc.; South San Francisco, CA USA
, Jeff Lutman Early PK/PD Department; Genentech, Inc.; South San Francisco, CA USA
, Renuka Sibia Biochemical and Cellular Pharmacology Department; Genentech, Inc.; South San Francisco, CA USA
, Pamela Chan Biochemical and Cellular Pharmacology Department; Genentech, Inc.; South San Francisco, CA USA
, Daniela Bumbaca Early PK/PD Department; Genentech, Inc.; South San Francisco, CA USA
, Paul Fielder Early PK/PD Department; Genentech, Inc.; South San Francisco, CA USA
, Paul J. Carter Antibody Engineering Department; Genentech, Inc.; South San Francisco, CA USA
& Robert F. Kelley Antibody Engineering Department; Genentech, Inc.; South San Francisco, CA USACorrespondence[email protected]
show all
Pages 753-760
|
Received 31 Jul 2012, Accepted 11 Sep 2012, Published online: 01 Nov 2012
Related Research Data
An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans
Source:
Informa UK Limited
In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus.
Source:
Informa UK Limited
High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy
Source:
Informa UK Limited
An engineered human IgG1 antibody with longer serum half-life.
Source:
The American Association of Immunologists
Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Screening antibody-antigen interactions in parallel using Biacore A100
Source:
Elsevier BV
Pharmacokinetics of Monoclonal Antibodies
Source:
Wiley
The Predictive Sample Reuse Method with Applications
Source:
Informa UK Limited
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules.
Source:
Nature Portfolio
Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring.
Source:
eScholarship, University of California
Preclinical and translational pharmacokinetics of a novel THIOMAB™ antibody-antibiotic conjugate against Staphylococcus aureus
Source:
Informa UK Limited
Determination of the net charge (valence) of a protein: a fundamental but elusive parameter
Source:
Elsevier BV
Neonatal Fc receptor and IgG-based therapeutics.
Source:
Informa UK Limited
An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.
Source:
Informa UK Limited
A High Through-put Platform for Recombinant Antibodies to Folded Proteins
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Immune repertoire mining for rapid affinity optimization of mouse monoclonal antibodies.
Source:
Informa UK Limited
High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice
Source:
Landes Bioscience
In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
Source:
Informa UK Limited
Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design
Source:
Springer Science and Business Media LLC
Enhanced antibody half-life improves in vivo activity
Source:
Springer Science and Business Media LLC
Biophysical properties of the clinical-stage antibody landscape
Source:
Proceedings of the National Academy of Sciences
Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates.
Source:
The American Association of Immunologists
Efficient production of antibodies against a mammalian integral membrane protein by phage display
Source:
Oxford University Press (OUP)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
Source:
Springer Science and Business Media LLC
Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis.
Source:
Informa UK Limited
Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibody.
Source:
Future Science Ltd
Characterization and screening of IgG binding to the neonatal Fc receptor
Source:
Informa UK Limited
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.